ROLE OF PRO-INFLAMMATORY CYTOKINE GENE POLYMORPHISMS IN PATIENTS WITH EARLY-ONSET VENOUS THROMBOEMBOLISM

Taking into account interrelations between inflammation and hemostasis, as well as immediate effects of IL-1β, IL-6 and TNFα upon blood coagulation system, one may suggest that their functional variants
could determine thrombosis risks both in arterial and venous circulation. The aim of this study was to assess possible role of allelic IL-1β, IL-6 and TNFα variants in pathogenesis of venous thromboembolism (VTE)
in young patients. A retrospective analysis was performed for a group of 180 patients with early-onset VTE, and 150 healthy. In a sub-group with deep-vein thrombosis of lower extremities (DWTLE) complicated by
pulmonary artery thromboembolia (PAT), we have revealed increased frequencies of IL-6 –174C homozygotes (30.8% vs 13.0%, p = 0.02) and IL-1β –31Т (61.5% vs 40.9%, p = 0.03), when compared with a subgroup of DWTLE. Among patients with “isolated” PAT a tendency for increased IL-1β –31ТТ ratio was found, as compared with DWTLE (53.8% vs 40.9%, р = 0,3), like as with control group (53.8% vs 40.7%, р = 0,3), These differences, however, were statistically insignificant. These data may suggest certain effects of IL-1β and IL-6 gene polymorphisms upon clinical characteristics of venous thromboembolism, rather than upon general VTE risk among young persons.

1. Barkagan Z.S. Kliniko-patogeneticheskie varianty, nomenklatura i osnovy diagnostic gematogennykh trombofiliy [Clinical and pathogenic variants, the nomenclature and diagnostic framework hematogenic thrombophilia]. Problemy gematologii – Issues of Hematology, 1996, no. 3, pp. 5-15.

2. Vardanyan A.V. Posleoperatsionnye venoznye tromboembolicheskie oslozhneniya – real`naya opasnost` i sovremennye metody profilaktiki [Postoperative venous thromboembolic complications – real danger and modern methods of prevention]. Angiologiya i sosudistaya khirurgiya – Angiology and Vascular Surgery, 2008, vol. 14, no. 1, pp. 67-72.

3. Kapustin S.I., Blinov M.N., Kargin V.D., Filanovskaya L.I., Saltykova N.B., Belyazo O.E., Golovina O.G., Shmeleva V.M., Panshina A.M., Papayan L.P. Geneticheskie determinanty nasledstvennoy trombofilii v patogeneze venoznogo tromboza [Genetical determinants of inherited thrombophilia in pathogenesis of venous thrombosis]. Terapevticheskiy arkhiv – The Therapeutic Archive, 2003, no. 10, pp. 78-80.

4. Polyakova A.P., Saltykova N.B., Kargin V.D., Vorob`eva N.A., Shmeleva V.M. Kapustin S.I. Osobennosti allel`nogo polimorfizma genov immunnogo otveta u bol`nykh s venoznym trombozom [The features of allelic polymorphism of immune response genes in patients with venous thrombosis. Materials of V All-Russian Conference “Clinical hemostasiology and hemoreology in cardiovascular surgery” (with international attendance)]. Moscow, 2011, pp. 416-417

5. Harchenko V.I., Kakorina E.P., Koryakin M.V., Virin M.M., Undritsov V.M., Smirnova N.L., Onishchenko P.I., Potievskiy B.G., Mikhaylova R.Yu. Smertnost` ot bolezney sistemy krovoobrashcheniya v Rossii i v ekonomicheski razvitykh stranakh. Neobkhodimost` usileniya kardiologicheskoy sluzhby i modernizatsii meditsinskoy statistiki v Rossiyskoy Federatsii [The cardiovascular diseases mortality in Russiaand developed countries. The necessity of intensification of Cardiological service and modernization of medical statistics in Russian Federation]. Rossiyskiy kardiologicheskiy zhurnal – Russian Cardiological Journal, 2005, no. 2, pp. 5-18.

6. Beckers M., Ruven H., Haas F. Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism. European Journal of Internal Medicine, 2010, vol. 21, no. 4, pp. 289-292.

7. Belfer I., Buzas B., Hipp H., Doevendans P.A., ten Cate H., Prins M.H., Biesma D.H. Haplotype structure of inflammatory cytokines genes (IL1B, IL6 and TNF/LTA) in US Caucasians and African Americans. Genes Immun., 2004, vol. 5, no. 6, pp. 505-512.

8. Chen H., Wilkins L.M., Aziz N., Cannings C., Wyllie D.H., Bingle C., Rogus J., Beck J.D., Offenbacher S., Cork M.J., Rafie-Kolpin M., Hsieh C.-M., Kornman K.S., Duff G. W. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Human Molecular Genetics, 2006, vol. 15, no. 4, pp. 519-529.

9. Christiansen S.C., N ss I.A., Cannegieter S.C., Hammerstrøm J., Rosendaal F.R., Reitsma P.H. Inflammatory Cytokines as Risk Factors for a First Venous Thrombosis: A Prospective Population-Based Study. Plos Med., 2006, vol. 3, no. 8, pp. 1414-1419.

10. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood, 1996, vol. 87, pp. 2095-2147.

11. El-Omar E.M., Carrington M., Chow W.-Ho, McColl K.E., Bream J.H., Young H.A., Herrera J.,Lissowska J., Yuan C.C., Rothman N., Lanyon G., Martin M., Fraumeni J.F.Jr., Rabkin C.S. Interleukin-1polymorphisms associated with increased risk of gastric cancer. Nature, 2000, vol. 404, no. 6776, pp. 398-402.

12. Fernandez-Real J.-M., Broch M., Vendrell J., Richart C., Ricart W. Interleukin-6 Gene Polymorphism and Lipid Abnormalities in Healthy Subjects. Journal of Clinical Endocrinology & Metabolism, 2000, vol. 85,no. 3, pp. 1334-1339.

13. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovascular Research, 2002, vol. 53, no. 1, pp. 31-47.

14. Franchini M., Lippi G., Manzato F. Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation. Thrombosis J., 2006, vol. 4, no. 1, pp. 4-15.

15. Guasch J.F., Bertina R.M., Reitsma P.H. Five novel intragenic dimorphisms in the human Interleukin-1 genes combine to high informativity. Cytokine, 1996, vol. 8, no. 8, pp. 598-602.

16. Hall S.K., Perregaux D.G., Gabel C.A., Woodworth T., Durham L.K., Huizinga T.W.F., Breedveld F.C., Seymour A.B. Correlation of polymorphic variation in the promoter region of the interleukin-1β gene with secretion of interleukin-1β protein. Arthritis & Rheumatism, 2004, vol. 50, no. 6, pp. 1976-1983.

17. Heit J.A., Melton III L.J., Lohse C.M., Petterson T.M., Silverstein M.D., Mohr D.N., O’Fallon W.M. Incidence of Venous Thromboembolism in hospitalized Patients vs Community Residents. Mayo Clin Proc., 2001, vol. 76, pp. 1102-1110.

18. Libby P., Ridker P.M., Maseri A. Inflammation and Atherosclerosis. Circulation, 2002, vol. 105, no. 9, pp. 1135–1143.

19. Miller S.A., Dykes D.D. and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res., 1988, vol. 16, no. 3, pp. 1215-1218.

20. Ohashi J., Naka I., Doi A., Patarapotikul J., Hananantachai H., Tangpukdee N., Looareesuwan S., Tokunaga K. A functional polymorphism in the IL1B gene promoter, IL1B -31C>T, is not associated with cerebral malaria in Thailand A functional polymorphism in the IL1B gene promoter, IL1B -31C>T, is not associated with cerebral malaria in Thailand. Malar J., 2005, vol. 4, no. 1, pp. 38-44.

21. Ozen S., Alikasifoglu M., Bakkaloglu A., Duzova A., Jarosova K., Nemcova D., Besbas N., Venkovsky J., Tunclilek E. Tumour necrosis factor alpha G->A -238 and G->A -308 polymorphisms in juvenile idiopathic arthritis. Rheumatology, 2002, vol. 41, no. 2, pp. 223-227.

22. Pet j J. Inflammation and coagulation. An overview. Thrombosis Research, 2011, vol. 127, pp. 34-37.

23. Reitsma P.H., Rosendaal F.R. Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J. Thromb. Haemost., 2004, vol. 2, no. 4, pp. 619-622.

24. Rosendaal F.R., Reitsma P.H. Genetics of venous thrombosis. Journal of Thrombosis and Haemostasis, 2009, vol. 7, pp. 301–304.

25. Steinbrugger I., Haas A., Maier R., Renner W., Mayer M., Werner C., Wedrich A., El-Shabrawi Y., Schmut O., Weger M. Analysis of inflammation- and atherosclerosis-related gene. Molecular Vision, 2009, vol. 15, pp. 609-618.

26. Ulfhammer E., Larsson P., Karlsson L., Hrafnkelsdottir T., Bokarewa M., Tarkowski A., Jern S. TNF-α mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NF-κBand p38 MAPK-dependent. J. Thromb. Haemost., 2006, vol. 4, no. 8, pp. 1781-1789.

27. van Aken B.E., den Heijer M., Bos G.M.J. Recurrent Venous Thrombosis and Markers of Inflammation. J. Thromb. Haemost., 2000, vol. 83, pp. 536-539.

28. van der Poll T., Levi M., Hack C.E., ten Cate H., van Deventer S.J.H., Eerenberg A.J.M., de Groot E.R., Jansen J., Gallati H., Bueller H.R., ten Cate J.W., Aarden L.A. Elimination of Interleukln 6 Attenuates Coagulation Activation in Experimental Endotoxemia in Chimpanzees. J. Exp. Med., 1994, vol. 179, pp. 1254-1259.

29. van Minkelen R., de Visser M.C.H., Houwing-Duistermaat J.J., Vos H.L., Bertina R.M., Rosendaal F.R. Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the Risk of Venous Thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 2007, vol. 27, no. 6, pp. 1486-1491.